Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other financing activities: 2017-2024

Historic Other financing activities for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $14.7 million.

  • Dianthus Therapeutics' Other financing activities was N/A to $2.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Dianthus Therapeutics' Other financing activities is $14.7 million, which was up 4,739.93% from $303,000 recorded in FY2021.
  • Over the past 5 years, Dianthus Therapeutics' Other financing activities peaked at $14.7 million during FY2024, and registered a low of $297,000 during FY2020.
  • Over the past 1 years, Dianthus Therapeutics' median Other financing activities value was $14.7 million (recorded in 2024), while the average stood at $14.7 million.
  • In the last 5 years, Dianthus Therapeutics' Other financing activities plummeted by 50.33% in 2020 and then climbed by 2.02% in 2021.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Other financing activities stood at $297,000 in 2020, then grew by 2.02% to $303,000 in 2021, then reached $14.7 million in 2024.